DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Bleph-10 is a drug marketed by Allergan and is included in two NDAs.
The generic ingredient in BLEPH-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
A generic version of BLEPH-10 was approved as sulfacetamide sodium by SANDOZ INC on October 18th, 1988.
Pharmacology for BLEPH-10
|Drug Class||Sulfonamide Antibacterial |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Allergan||BLEPH-10||sulfacetamide sodium||OINTMENT;OPHTHALMIC||084015-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|Allergan||BLEPH-10||sulfacetamide sodium||SOLUTION/DROPS;OPHTHALMIC||080028-001||Approved Prior to Jan 1, 1982||AT||RX||No||Yes||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|